This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Still, PET imaging in breast cancer may be among this year’s hottest topics, with studies suggesting FDG-PET/MRI may be reliable in newly diagnosed patients and another revealing which potential tracer is more effective in women with metastatic lesions, namely F-18 fluciclovine or Ga-68 PSMA. 9:30 a.m. | Monday, November 27 | 8:30 a.m.-8:40
FDG-PET/CT provides functional insights by detecting metabolic changes before structural alterations, making it valuable for therapy response monitoring, but it has limitations in visualizing metabolically silent bone metastases, according to Masperi and Girlando. Scans were conducted using two CT systems (Somatom go.Top from Siemens).
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
2023 
290 
Let's personalize your content